UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib

European journal of cancer (1990), 2009-09, Vol.45 (13), p.2293-2297

2009

Link zum Volltext

Verfügbarkeit prüfen

Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells

Leukemia, 2011-01, Vol.25 (1), p.89-100

2011

Link zum Volltext

Verfügbarkeit prüfen

Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies

Oncogene, 2013-02, Vol.32 (8), p.1066-1072

2013

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia

Leukemia, 2015-04, Vol.29 (4), p.981-984

2015

Link zum Volltext

Verfügbarkeit prüfen

Erratum zu: Seltene Ursache einer progredienten Sprachstörung

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2014, Vol.109 (1), p.51-51

2014

Link zum Volltext

Verfügbarkeit prüfen

1LBA Impact of regional hyperthermia (RHT) on response to neo-adjuvant chemotherapy and survival of patients with high-risk soft-tissue sarcoma (HR-STS): Results of the randomized EORTC-ESHO intergroup trial (NCI-00003052)

European journal of cancer supplements, 2009, Vol.7 (3), p.2-2

2009

Link zum Volltext

Verfügbarkeit prüfen

EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NHL: RESULTS OF THE PHASE III MABCUTE STUDY

Hematological oncology, 2019-06, Vol.37 (S2), p.229-231

2019

Link zum Volltext

Verfügbarkeit prüfen

Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients

Journal of the American Academy of Dermatology, 2000-09, Vol.43 (3), p.477-482

2000

Link zum Volltext

Verfügbarkeit prüfen

CHARACTERISTICS, TREATMENT, AND OUTCOMES OF ≥ 80 YEAR OLD PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ENROLLED TO PROSPECTIVE TRIALS OF THE GERMAN CLL STUDY GROUP

Hematological oncology, 2017-06, Vol.35 (S2), p.99-100

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification of native, immunogenic peptides from Cyclin D1

Leukemia, 2010-01, Vol.24 (1), p.209-211

2010

Link zum Volltext

Verfügbarkeit prüfen

BENDAMUSTINE (B), FOLLOWED BY OBINUTUZUMAB (G) AND VENETOCLAX (A) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLL2‐BAG TRIAL OF THE GERMAN CLL STUDY GROUP (GCLLSG)

Hematological oncology, 2017-06, Vol.35 (S2), p.25-27

2017

Link zum Volltext

Verfügbarkeit prüfen

Ifosfamide with Regional Hyperthermia in Soft-Tissue Sarcomas

Oncology, 2003-01, Vol.65 (2), p.76-79

2003

Link zum Volltext

Verfügbarkeit prüfen

Redefining the therapeutic goals in chronic lymphocytic leukemia: Towards an evidence-based, risk-adapted therapy

Annals of oncology, 1999-05, Vol.10 (5), p.505-509

1999

Link zum Volltext

Verfügbarkeit prüfen

Strategies for the development of a tumor vaccine for non-Hodgkin's lymphoma

European journal of cancer (1990), 1995-10, Vol.31, p.S18-S18

1995

Link zum Volltext

Verfügbarkeit prüfen

Quality assurance in MRI assisted treatment planning: comparison of imaging accuracy at different MRI units based on phantom measurements

International journal of radiation oncology, biology, physics, 1993, Vol.27, p.302-302

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(15)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib

Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells

Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies

Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia

Erratum zu: Seltene Ursache einer progredienten Sprachstörung

1LBA Impact of regional hyperthermia (RHT) on response to neo-adjuvant chemotherapy and survival of patients with high-risk soft-tissue sarcoma (HR-STS): Results of the randomized EORTC-ESHO intergroup trial (NCI-00003052)

EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NHL: RESULTS OF THE PHASE III MABCUTE STUDY

Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients

CHARACTERISTICS, TREATMENT, AND OUTCOMES OF ≥ 80 YEAR OLD PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ENROLLED TO PROSPECTIVE TRIALS OF THE GERMAN CLL STUDY GROUP

Identification of native, immunogenic peptides from Cyclin D1

BENDAMUSTINE (B), FOLLOWED BY OBINUTUZUMAB (G) AND VENETOCLAX (A) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLL2‐BAG TRIAL OF THE GERMAN CLL STUDY GROUP (GCLLSG)

Ifosfamide with Regional Hyperthermia in Soft-Tissue Sarcomas

Redefining the therapeutic goals in chronic lymphocytic leukemia: Towards an evidence-based, risk-adapted therapy

Strategies for the development of a tumor vaccine for non-Hodgkin's lymphoma

Quality assurance in MRI assisted treatment planning: comparison of imaging accuracy at different MRI units based on phantom measurements

Suchergebnisse filtern